WELLS FARGO & COMPANY/MN - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4,500
-100.0%
3,000
-100.0%
0.00%
-100.0%
Q2 2023$17,019,090
-31.0%
13,378,000
-27.1%
0.01%
-28.6%
Q1 2023$24,676,585
-14.5%
18,354,0000.0%0.01%
-22.2%
Q4 2022$28,849,185
-22.3%
18,354,000
-33.1%
0.01%
-25.0%
Q3 2022$37,116,000
-0.2%
27,422,000
-1.8%
0.01%0.0%
Q2 2022$37,194,000
-6.5%
27,927,000
-8.3%
0.01%
+20.0%
Q1 2022$39,798,000
+1.2%
30,444,000
-3.5%
0.01%0.0%
Q4 2021$39,344,000
-2.3%
31,553,000
+3.9%
0.01%
+11.1%
Q3 2021$40,261,000
+25.2%
30,367,000
+26.2%
0.01%
+28.6%
Q2 2021$32,159,000
+1.6%
24,055,000
+2.1%
0.01%0.0%
Q1 2021$31,668,000
+37.8%
23,556,000
+41.4%
0.01%
+16.7%
Q4 2020$22,979,000
-28.1%
16,654,000
-28.3%
0.01%
-33.3%
Q3 2020$31,939,000
-1.8%
23,228,000
+18.8%
0.01%0.0%
Q2 2020$32,515,000
-20.4%
19,556,000
-38.6%
0.01%
-35.7%
Q1 2020$40,827,000
-6.4%
31,859,000
+11.9%
0.01%
+16.7%
Q4 2019$43,600,000
+18.4%
28,472,000
+5.9%
0.01%
+20.0%
Q3 2019$36,818,000
-6.4%
26,890,000
-10.3%
0.01%
-9.1%
Q2 2019$39,336,000
-3.0%
29,982,000
-0.1%
0.01%
-8.3%
Q1 2019$40,553,000
+108.1%
30,008,000
+83.8%
0.01%
+100.0%
Q4 2018$19,491,000
-54.0%
16,329,000
-34.3%
0.01%
-50.0%
Q3 2018$42,366,000
+59.0%
24,854,000
+34.6%
0.01%
+50.0%
Q2 2018$26,643,00018,461,0000.01%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders